[go: up one dir, main page]

TR200100948T2 - Cinsel yoldan bulaşan hastalıklara karşı aşı - Google Patents

Cinsel yoldan bulaşan hastalıklara karşı aşı

Info

Publication number
TR200100948T2
TR200100948T2 TR200100948T TR200100948T TR200100948T2 TR 200100948 T2 TR200100948 T2 TR 200100948T2 TR 200100948 T TR200100948 T TR 200100948T TR 200100948 T TR200100948 T TR 200100948T TR 200100948 T2 TR200100948 T2 TR 200100948T2
Authority
TR
Turkey
Prior art keywords
sexually transmitted
transmitted diseases
vaccine against
prevent
treat
Prior art date
Application number
TR200100948T
Other languages
English (en)
Inventor
Mohamed Slaoui Moncef
G. Vandepapeliere Pierre
Original Assignee
Smithkline Beecham Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10838766&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200100948(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Biologicals S.A. filed Critical Smithkline Beecham Biologicals S.A.
Publication of TR200100948T2 publication Critical patent/TR200100948T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Cinsel yoldan bulasan hastaliklara neden olan patojenler ile iliskili enfeksiyonlari önlemek ya da tedavi etmek için, kadinlara bir asinin tatbik edilme yöntemi tarif edilir. Asi, cinsel yoldan bulasan hastaliklarin önlenmesi ya da tedavi edilmesi için bir ya da daha fazla antijeni, örnegin; HSV glikoprotein D ya da bunun immünolojik bir parçasi ve bir adjuvani, özellikle de bir TH-1 indükleyici adjuvani kapsar. Kadinlarda cinsel yoldan bulasan hastaliklarin önlenmesi ya da tedavi edilmesi için, bir asi bilesiminin formülasyonu için asi bilesenlerinin kullanilmasi da tarif edilmektedir.
TR200100948T 1998-09-11 1999-09-08 Cinsel yoldan bulaşan hastalıklara karşı aşı TR200100948T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9819898A GB9819898D0 (en) 1998-09-11 1998-09-11 New vaccine and method of use

Publications (1)

Publication Number Publication Date
TR200100948T2 true TR200100948T2 (tr) 2001-07-23

Family

ID=10838766

Family Applications (1)

Application Number Title Priority Date Filing Date
TR200100948T TR200100948T2 (tr) 1998-09-11 1999-09-08 Cinsel yoldan bulaşan hastalıklara karşı aşı

Country Status (28)

Country Link
EP (1) EP1109574B1 (tr)
JP (1) JP2002524532A (tr)
KR (1) KR100777896B1 (tr)
CN (2) CN1325311A (tr)
AR (1) AR021798A1 (tr)
AT (1) ATE392214T1 (tr)
AU (1) AU744989B2 (tr)
BR (1) BR9913630A (tr)
CA (1) CA2343399C (tr)
CO (1) CO5090882A1 (tr)
CY (1) CY1108147T1 (tr)
CZ (1) CZ302808B6 (tr)
DE (1) DE69938555T2 (tr)
DK (1) DK1109574T3 (tr)
ES (1) ES2304068T3 (tr)
GB (1) GB9819898D0 (tr)
HU (1) HUP0104297A3 (tr)
IL (1) IL141843A0 (tr)
MY (1) MY122216A (tr)
NO (1) NO329522B1 (tr)
NZ (1) NZ510425A (tr)
PL (1) PL199545B1 (tr)
PT (1) PT1109574E (tr)
SI (1) SI1109574T1 (tr)
TR (1) TR200100948T2 (tr)
TW (1) TWI225790B (tr)
WO (1) WO2000015255A1 (tr)
ZA (1) ZA200101987B (tr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000087I1 (de) 1998-10-16 2008-03-27 Glaxosmithkline Biolog Sa Adjuvanzsysteme und impfstoffe
GB9921146D0 (en) 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
EP2583678A3 (en) 2004-06-24 2013-11-13 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
EP2360175B1 (en) 2005-11-22 2014-07-16 Novartis Vaccines and Diagnostics, Inc. Norovirus and Sapovirus virus-like particles (VLPs)
EP2368570A3 (en) 2006-01-18 2012-05-02 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
RU2471497C2 (ru) 2007-09-12 2013-01-10 Новартис Аг Мутантные антигены gas57 и антитела против gas57
GB0818453D0 (en) 2008-10-08 2008-11-12 Novartis Ag Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
ES2596653T3 (es) 2009-06-16 2017-01-11 Glaxosmithkline Biologicals Sa Ensayos bactericidas de opsonización y dependientes de anticuerpo mediado por el complemento de alto rendimiento
WO2011026111A1 (en) 2009-08-31 2011-03-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Oral delivery of a vaccine to the large intestine to induce mucosal immunity
CA2795403C (en) 2010-04-08 2019-01-15 University Of Pittsburgh-Of The Commonwealth System Of Higher Education B-cell antigen presenting cell assay
EP2575988A1 (en) 2010-05-28 2013-04-10 Tetris Online, Inc. Interactive hybrid asynchronous computer game infrastructure
WO2013006569A2 (en) 2011-07-01 2013-01-10 The Regents Of The University Of California Herpes virus vaccine and methods of use
US11071745B2 (en) 2014-07-07 2021-07-27 Elian Llc Viral prophylaxis treatment methods and pre-exposure prophylaxis kits
BR112017000285A2 (pt) * 2014-07-07 2017-10-31 Prophylaxis LLC métodos de tratamento da profilaxia viral e kits de profilaxia de pré-exposição
US10962534B2 (en) 2016-02-22 2021-03-30 Boehringer Ingelheim Vetmedica Gmbh Method for the immobilization of biomolecules
WO2020086408A1 (en) 2018-10-26 2020-04-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services A high-yield perfusion-based transient gene expression bioprocess

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
US5776468A (en) * 1993-03-23 1998-07-07 Smithkline Beecham Biologicals (S.A.) Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A
GB9326253D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
GB9506863D0 (en) * 1995-04-03 1995-05-24 Smithkline Beecham Biolog Vaccines

Also Published As

Publication number Publication date
KR100777896B1 (ko) 2007-11-27
DE69938555T2 (de) 2009-06-10
CY1108147T1 (el) 2014-02-12
CA2343399A1 (en) 2000-03-23
CN101130070A (zh) 2008-02-27
EP1109574B1 (en) 2008-04-16
PL346651A1 (en) 2002-02-25
AR021798A1 (es) 2002-08-07
DK1109574T3 (da) 2008-06-30
EP1109574A1 (en) 2001-06-27
SI1109574T1 (sl) 2008-08-31
NO20011193D0 (no) 2001-03-08
AU5975299A (en) 2000-04-03
NO20011193L (no) 2001-05-09
HUP0104297A2 (hu) 2002-03-28
NO329522B1 (no) 2010-11-01
CA2343399C (en) 2010-08-03
HK1037978A1 (en) 2002-03-01
PT1109574E (pt) 2008-06-12
GB9819898D0 (en) 1998-11-04
PL199545B1 (pl) 2008-09-30
CO5090882A1 (es) 2001-10-30
CZ2001887A3 (cs) 2001-10-17
MY122216A (en) 2006-03-31
ATE392214T1 (de) 2008-05-15
HUP0104297A3 (en) 2004-10-28
NZ510425A (en) 2003-04-29
DE69938555D1 (de) 2008-05-29
ZA200101987B (en) 2002-05-09
KR20010075049A (ko) 2001-08-09
CN1325311A (zh) 2001-12-05
TWI225790B (en) 2005-01-01
BR9913630A (pt) 2001-05-22
IL141843A0 (en) 2002-03-10
JP2002524532A (ja) 2002-08-06
ES2304068T3 (es) 2008-09-01
CZ302808B6 (cs) 2011-11-23
WO2000015255A1 (en) 2000-03-23
AU744989B2 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
TR200100948T2 (tr) Cinsel yoldan bulaşan hastalıklara karşı aşı
MY111880A (en) Hepatitis vaccines containing 3-0 deacylated monophosphoryl lipid a
ES2149276T3 (es) Imidazo(4,5-c)piridin-4-aminas.
MX9301706A (es) Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
AP2000001886A0 (en) Group B streptococcus antigens.
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
MY134811A (en) A vaccine composition comprising an antigen, a saponin and a sterol
AP2001002199A0 (en) Novel streptococcus antigens
ATE262348T1 (de) Mittel zur verabreichung von antigenen
UA40597C2 (uk) Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
AU2684792A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
TR199801722T2 (tr) Peptit immünojenler.
YU28392A (sh) Vakcina koja sadrži glikoprotein d i 3deacilovani monofosforil lipid a
MA28149A1 (fr) Compositions de vaccin comprenant une interleukine 18 et un systeme adjuvant de type saponine
DE69734605D1 (de) Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung
AR014182A1 (es) Composiciones de vacunas utiles para el tratamiento o profilaxis de tumores o lesiones inducidas por hpv; procedimiento para prevenir o tratar tumoresinducidos por hpv y procedimiento para preparar dichas composiciones
DE69425427D1 (de) Ein pharmazeutisches präparat zur topischen verabreichung von antigenen und/oder vakzinen an die schleimhäute von säugern
NZ337885A (en) vaccine formulation of an antigen, a TH-1 inducing adjuvant and a sparingly water soluble amino acid
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe
PT745388E (pt) Composicao de vacinas para mamiferos compreendendo esqualeno ou esqualano fosfolipido e um tensioactivo como adjevante
DE69527986D1 (de) Antigene arznei zur behandlung oder vorbeugung
EP0716613A4 (en) TREATING A GASTRODUODENAL DISEASE CAUSED BY -i (HELICOBAKTER PYLORI)
HUP9801223A2 (hu) Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel
EP0954529A4 (en) Porphyromonas gingivalis antigen for the diagnosis and treatment of periodontitis
ES2096988T3 (es) Organopolisiloxanos que contienen grupos hidrofilos.